Skip to main content
Spinal muscular atrophy: Patient care in the age of genetically targeted therapy
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Spinal muscular atrophy: Patient care in the age of genetically targeted therapy
User login
Username
Password
Reset your password
Concept
Lead
score
Muscular Atrophy
1
1
Spinal Muscular Atrophy
0
1
Newborn Screening
0
0.54
Genomic Medicine
0
0.85
Newborn
0
0.43
Healthcare and Medical Technology
0
0.33
Clinical Guidelines
0
0.28
Treatment Guidelines
0
0.28
Biologic Therapy
0
0.24
Child
0
0.21
Clinical Research
0
0.21
Neuron
0
0.21
Acute Liver Failure
0
0.2
Genetics
0
0.18
Muscle
0
0.18
Genetic Disorders
0
0.17
Genetic Testing
0
0.17
Liver Failure
0
0.17
Gene Therapy
0
0.15
Birth
0
0.12
Liver
0
0.12
Animal Research
0
0.09
Primary Care
0
0.09
Targeted Cancer Therapy
0
0.09
Mechanical Ventilation
0
0.08
Biomarker
0
0.06
Dorsum
0
0.06
Injury
0
0.06
Referral
0
0.06
Weakness
0
0.06
Wound Management
0
0.06
Ethics
0
0.05
Corticosteroid Taper
0
0.04
Patient Safety
0
0.04
Adolescent Medicine
0
0.03
Adverse Effects
0
0.03
Blood
0
0.03
Corticosteroids
0
0.03
Drug Development
0
0.03
Europe
0
0.03
Face
0
0.03
Hawaii
0
0.03
Hospital
0
0.03
Immunization
0
0.03
Intravenous
0
0.03
Medical Life
0
0.03
Meta-Analysis
0
0.03
Mobility
0
0.03
Nevada
0
0.03
Nutrition
0
0.03
Orbit
0
0.03
Palliative Care
0
0.03
Pharmacogenomics
0
0.03
Physiology
0
0.03
Plasma
0
0.03
Prognosis
0
0.03
South Carolina
0
0.03
Washington
0
0.03
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Family Medicine/Primary Care
0
1
Pediatrics
0
1
Pharmacist
0
0.26
Pathology & Lab Medicine
0
0.24
Infectious Diseases
0
0.21
Nursing
0
0.05
Hospital Medicine
0
0.03
Edit Tags